The practice of self medication is continuously increasing worldwide due to its important roles in curing minor conditions or symptoms. This study was conducted to evaluate the factors associated with self medication practice of Iraqi respondents residing in Baghdad City. This study was designed as cross sectional study in which data was collected via direct interviews with respondents using a previously prepared questionnaire. This study investigated 348 respondents from different age groups. The majority of respondents were male aged between 30-60 years, married with secondary or academic level of education and employed with accepted monthly income. The main reason for practicing self medication was previous experience with the same condition followed by considering the current condition simple with no need to consult a physician. A previous prescription was revealed to be the commonest source of information about the self medicated drugs followed by community pharmacies and family members or friends. Flu or common cold was the commonest indication identified for self medication followed by headache, back or muscle pain, dyspepsia, diarrhea and others. Drugs used in treating these conditions were antibiotics, the commonest, followed by paracetamol, antihistamines, non-steroidal anti-inflammatory drugs, cough preparations, antispasmodics, skeletal muscle relaxants, antacids, antidiarrheals and others.
There are a few studies that discuss the medical causes for diabetic foot (DF) ulcerations in Iraq, one of them in Wasit province. The aim of our study was to analyze the medical, therapeutic, and patient risk factors for developing DF ulcerations among diabetic patients in Baghdad, Iraq.
BackgroundDuring Ramadan, Muslims fast throughout daylight hours. There is a direct link between fasting and increasing incidence of infections. Antibiotic usage for treatment of infections should be based on accurate diagnosis, with the correct dose and dosing regimen for the shortest period to avoid bacterial resistance. This study aimed to evaluate the practices of physicians in prescribing suitable antibiotics for fasting patients and the compliance of the patients in using such antibiotics at regular intervals.Materials and methodsAn observational study was carried out during the middle 10 days of Ramadan 2014 in two pharmacies at Baghdad. A total of 34 prescriptions (Rx) for adults who suffered from infections were examined. For each included Rx, the researchers documented the age and sex of the patient, the diagnosis of the case, and the name of the given antibiotic(s) with dose and frequency of usage. A direct interview with the patient was also done, at which each patient was asked about fasting and if he/she would like to continue fasting during the remaining period of Ramadan. The patient was also asked if the physician asked him/her about fasting before writing the Rx.ResultsMore than two-thirds of participating patients were fasting during Ramadan. Antibiotics were prescribed at a higher percentage by dentists and surgeons, for which a single antibiotic with a twice-daily regimen was the most commonly prescribed by physicians for patients during the Ramadan month.ConclusionPhysicians fail to take patient fasting status into consideration when prescribing antibiotics for their fasting patients. Antibiotics with a twice-daily regimen are not suitable and best to be avoided for fasting patients in Iraq during Ramadan – especially if it occurs during summer months – to avoid treatment failure and provoking bacterial resistance.
Recently, microRNAs (miRNAs) which are non-coding small RNAs that negatively control gene expressions displayed an important role in the regulation of gene expression in various cells of the skin, including stem cells, immune cells, and keratinocytes (Xu et al., 2014). Moreover, several miRNAs were shown to be differentially expressed in diabetic skins and their expression levels varied during the wound healing process (Madhyastha et al., 2012). For instance, miRNA-126 depletion causes defective endothelial cell proliferation, migration, and angiogenesis contributed by elevated levels of miRNA-503 which is specially grown in diabetes resulting in impaired wound healing via persistent
Until today, one of the leading predominant infections is Urinary tract infection (UTI). It exerts a huge burden on health systems worldwide each year. Treating UTIs empirically with antimicrobials improves morbidity rates. This study aims to assess the prevalence of UTI-associated bacteria in adult patients and to determine their antibiotic susceptibility profile. A retrospective study was conducted for adult outpatients who visited Al-Diwaniya tertiary hospitals from January 2020 till February 2022 to review their medical and lab records in addition to sociodemographic data. A total of 256 patients’ records were included of which 204 (79.7%) belong to females and 52 (20.3%) were males with an average age of 39.22±17.10 years. The predominant organisms’ isolates were Staphylococcus spp. found in 100 records (39.1%), Escherichia coli (E. coli) demonstrated in 90 records (35.2%), and Klebsiella spp. (K. spp.) revealed in 23 records (9%). Staphylococcus spp. (Staph. spp.) showed high resistance to ampicillin (92.9%) followed by ceftazidime (87.5%), and were highly sensitive to vancomycin. The higher resistance profile of E. coli was to ampicillin (97.9%) and ceftriaxone (81.3%) while was highly susceptible to meropenem (97.9%) and amikacin (97.6%). Additionally, Klebsiella spp. was highly susceptible to nitrofurantoin (78.6%), while was completely resistant to ampicillin. This study presents Staphylococcus spp. as the most prevalent gram-positive uropathogen and E. coli as the most prevalent gram-negative bacteria with a multidrug resistance profile to commonly used antimicrobials which is an alarming situation to implement an immediate effective stewardship program.
Background: Asthma is a complicated condition characterized by chronic airway inflammation and airflow restriction, resulting in various respiratory symptoms such as shortness of breath, wheezing, coughing, and chest tightness. The research intended to evaluate and compare the clinical outcomes of two interchangeable treatment regimens administered to a group of Iraqi asthmatic children. Methods: This observational clinical study was conducted on a sample of pediatric Iraqi asthmatic patients in the central pediatric hospital in Baghdad. The study enrolled asthmatic children with moderate persistent asthma, who a specialized physician had diagnosed. Patients had been allocated to two groups to receive either medium doses of beclomethasone inhaler (80 μg twice a day) for group one, or low doses (40 μg twice a day) plus montelukast chewable tablets (5 mg once daily) for group two. This study used the Child Health Survey-child version (CHS-child version) to investigate the quality of life of included patients. Also, this study investigated the inflammatory blood markers; (eosinophils and prostaglandin D2).Results: This research included 63 patients ranging in age from 7 to 11 years, with a slight male preponderance: group one patients (n=30) and group two patients (n=33). Compared with baseline levels, the study groups had considerably higher quality of life scores at the first follow-up visit (P<0.05). After that, the two groups' scores were nonsignificantly higher at the second follow-up visit compared with the first follow-up visit (P>0.05). Both groups significantly improved inflammatory biomarkers at the first follow-up visit (P <0.05). The second follow-up visit revealed further improvement in both groups. Open Peer Review Approval Status AWAITING PEER REVIEWAny reports and responses or comments on the article can be found at the end of the article.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.